Prosecution Insights
Last updated: August 15, 2026

United Kingdom Research and Innovation

8 pending office actions • 7 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 11 patents granted in the last 365 days

Portfolio Summary

8
Total Pending OAs
8
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
1
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (12%)
4
Medium (50%)
3
Easy (38%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (12%)
§102 only1 (12%)
§112 only2 (25%)
Double-patenting only1 (12%)
Double-patenting + other2 (25%)
Multi-statute (no §101)1 (12%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

7
Life Sciences
88% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
12% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

80 h
Manual time on pending OAs
16 h
Time saved (low, 20%)
28 h
Time saved (mid, 35%)
0.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MOAZZAMI, NAGHMEH NINA 1 73.5% +42.1%
SWIFT, CANDICE LEE 1 57.4% +36.7%
MCKOY, QUINCY ANDRE 1 70.3% +39.6%
ORWIG, KEVIN S 1 25.2% +39.8%
KIEFER, DALTON EDWARD 1
OUSPENSKI, ILIA I 1 77.5% +20.4%
BUNKER, AMY M 1 29.1% +45.3%
MARTINEZ, TARA L 1 62.7% +65.0%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18305932 COMPARTMENTALISED COMBINATORIAL CHEMISTRY BY MICROFLUIDIC CONTROL BUNKER, AMY M 23d overdue
18365709 COMBINED SURFACE ENHANCED AND SPATIALLY OFFSET RAMAN SPECTROSCOPY FOR BIOMOLECULE DETECTION ORWIG, KEVIN S

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18305932 COMPARTMENTALISED COMBINATORIAL CHEMISTRY BY MICROFLUIDIC CONTROL BUNKER, AMY M 23d overdue
17100889 CELL PENETRATING MOLECULE MARTINEZ, TARA L 75d
18710471 COMPOUNDS FOR TREATING MITOCHONDRIAL DNA DISORDERS MOAZZAMI, NAGHMEH NINA
18690456 NUCLEIC ACID POLYMERASE AND ITS USE IN PRODUCING NON-DNA NUCLEOTIDE POLYMERS SWIFT, CANDICE LEE
18690114 AMINOPYRIDINES AS ACTIVATORS OF PI3 KINASE MCKOY, QUINCY ANDRE
18365709 COMBINED SURFACE ENHANCED AND SPATIALLY OFFSET RAMAN SPECTROSCOPY FOR BIOMOLECULE DETECTION ORWIG, KEVIN S
18037063 COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTESTINAL CANCER OUSPENSKI, ILIA I

Top Art Units

Art UnitApps
1652 2
1657 1
1626 1
3991 1
1644 1
1684 1
1654 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18710471 COMPOUNDS FOR TREATING MITOCHONDRIAL DNA DISORDERS MOAZZAMI, NAGHMEH NINA 1652 §103 Non-Final OA Pending May 15, 2024
18690456 NUCLEIC ACID POLYMERASE AND ITS USE IN PRODUCING NON-DNA NUCLEOTIDE POLYMERS SWIFT, CANDICE LEE 1657 DP Non-Final OA Pending Mar 08, 2024
18690114 AMINOPYRIDINES AS ACTIVATORS OF PI3 KINASE MCKOY, QUINCY ANDRE 1626 §102 Non-Final OA Pending Mar 07, 2024
18365709 COMBINED SURFACE ENHANCED AND SPATIALLY OFFSET RAMAN SPECTROSCOPY FOR BIOMOLECULE DETECTION ORWIG, KEVIN S 3991 §112 Non-Final OA Pending Feb 05, 2024
18547085 FUSION PROTEINS COMPRISING TWO RING DOMAINS KIEFER, DALTON EDWARD 1652 §102§112DP Non-Final OA Pending Aug 18, 2023
18037063 COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTESTINAL CANCER OUSPENSKI, ILIA I 1644 §102§103§112DP Non-Final OA Pending May 15, 2023
18305932 COMPARTMENTALISED COMBINATORIAL CHEMISTRY BY MICROFLUIDIC CONTROL BUNKER, AMY M 1684 §102§103§112Other Non-Final OA 23d overdue Pending Apr 24, 2023
17100889 CELL PENETRATING MOLECULE MARTINEZ, TARA L 1654 §112 Non-Final OA 75d Pending Nov 22, 2020

Managing United Kingdom Research and Innovation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month